Joint action
With wounds being one of the more common reasons for prescribing antibiotics, EWMA believes that it is incumbent to play an active role in combatting the overuse of antibiotics. This is why EWMA since 2013 has had AMR at the top of its agenda, and initiated a range of activities targeted at raising awareness about the prudent use of antibiotics in wound care, which largely means following the principles of antimicrobial stewardship.
Combatting AMR is a multifaceted challenge that requires collaboration across sectors. EWMA is delighted to continue the partnership with the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), having previously been a partner in EU-JAMRAI 1.
EU-JAMRAI 2
EU-JAMRAI 2 is a four-year project (2024-2027) aiming at supporting the 30 Member States and associated countries in developing and updating their National Action Plan (NAP) on AMR.
The project will propose concrete measures to strengthen the implementation of efficient, evidence-based, and sustainable policies to tackle AMR and healthcare-associated infections (HAI) in line with the One Health perspective.
It focuses on several key areas, including AMS, surveillance, awareness raising, capacity building, infection prevention and control (IPC), and behavioral science. Over the next four years, EU-JAMRAI 2, together with its partners and stakeholders, will work together to support the national health systems in protecting people from AMR following the One Health approach.
EU-JAMRAI 2 is funded by the member states and by the EU4Health Program of the European Union.
About the European Network for Infection Prevention and Antimicrobial Resistance Founded in March 2024, the European Network for Infection Prevention and Antimicrobial Resistance (ENIPAR), consisting of stakeholders such as academics, patient groups and healthcare professionals, is committed to implementing effective infection prevention and control measures and policies in healthcare settings and in the community, and to promoting prudent and sustainable use of antibiotics in the community, long-term care facilities and healthcare settings.
The ENIPAR aims to be a vigilant body, fostering dialogue among relevant stakeholders, supporting European and national initiatives to educate and promote awareness on the root causes of AMR, including the urgent threat of multidrug resistance caused by the WHO-classified pathogens, and proposing solutions and highlighting best practices to reduce and monitor AMR, leading to improved patient and healthcare worker safety.
